LigandScout Software Suite – License Renewal

Closed Special Notice Posted

Solicitation number
75N95024Q00416
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
513210 Software Publishers
Place of performance
Rockville, Maryland 20850, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health (NIH) National Institute on Drug Abuse has issued a Special Notice for the sole-source procurement of the LigandScout software suite license renewal. The NIH intends to negotiate a contract with Inte:ligand Softwareentwicklungs- und Consulting GmbH, the sole provider of the required software.

The purpose of this procurement is to renew the annual license for the LigandScout software suite, which supports early drug discovery research through computer-aided design solutions. The contract will cover an unlimited number of seats for a one-year period from September 26, 2024, to September 25, 2025. This procurement will be conducted under the simplified acquisition procedures of the Federal Acquisition Regulation, which allows for sole-source contracting when only one source is reasonably available. Interested parties may submit capability statements, proposals, or quotations by the July 29, 2024, due date, but a determination to proceed with sole-source contracting is at the sole discretion of the government.

Notice text

NOTICE OF INTENT to Sole Source

  1. SOLICITATION NUMBER: 75N95024Q00416
  2. TITLE:  LigandScout Software Suite – License Renewal
  3. CLASSIFICATION CODE:

7A20 – IT AND TELECOM - APPLICATION DEVELOPMENT SOFTWARE

NAICS CODE: 513210 - Software Publishers

RESPONSE DATE:

July 29, 2024 at 12:00 PM EST

  1. PRIMARY POINT OF CONTACT:

Maggie Brant

Maggie.brant@nih.gov

Phone: 301.827.1771

  1. DESCRIPTION:

INTRODUCTION

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Center for Advancing Translational Sciences (NCATS) intends to negotiate on a sole source basis with Inte:ligand Softwareentwicklungs- und Consulting GmbH for LigandScout Expert Remote Execution, unlimited seats floating license, 1 year including the Inte:Ligand Expert KNIME Extensions.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE and SET ASIDE STATUS

The intended procurement is classified under NAICS code 513210 - Software Publishers with a Size Standard of $47 million.  

REGULATORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures. Contracts awarded using FAR Part 13—Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6—Competition Requirements. FAR Subpart 13.106-1 (b) Soliciting from a single source provides that: For purchases not exceeding the simplified acquisition threshold, Contracting officers may solicit from one source IF the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name OR industrial mobilization).

The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2024-05 dated May 22, 2024.

DESCRIPTION OF REQUIREMENT

PURPOSE AND OBJECTIVES:

The National Center for Advancing Translational Sciences (NCATS) Division of Preclinical Innovation (DPI) is in need of the LigandScout annual license for software that supports scientists worldwide with innovative approaches for early drug discovery research by developing and applying computer- aided design (CAD) solutions. The requirement is for the LigandScout software suite that will aid in 3D SAR (structure activity relationship) analysis, generate novel and diverse structures using bioisosteres, and understanding SAR and design.

SPECIFIC REQUIREMENTS:

  1. Structure-based 3D Molecular Design
  2. Automatic interpretation of PDB ligands using geometry, dictionaries and rules
  3. State-of-the-art user interface with advanced 3D graphics and undo-function
  4. 2D view and hierarchical view directly linked to 3D interface
  5. Fast alignment of molecules in their bio-active conformation to other molecules and 3D pharmacophores from several ligands and/or pharmacophores, shared feature pharmacophores can be derived to understand and model the relevant mode of action
  6. Advanced handling of co-factors, ions, water molecules and covalently bound ligand
  7. Extensive parameter control for more experienced users
  8. Advanced PDB ligand perception and easy manual correction while modeling in the active site
  9. Ability to treat co-factors and water molecules as part of the ligand or part of the macromolecule
  10. Intuitive pharmacophore-based alignment of molecules
  11. Support for most common file formats
  12. Sophisticated file and repository management of edited and stored binding sites, molecules and pharmacophores
  13. Smart enumeration of tautomers
  14. Accurate and Fast Virtual Screening
  15. High performance accurate virtual screening with automated analysis of screening performance using ROC curves and enrichment factor calculations
  16. Simple workflows for boolean combination of target and anti-target pharmacophore models
  17. Easy to use implementation of AutoDock 4.2 and AutoDock Vina
  18. Accurate implementation of the MMFF94 force field for generating high quality geometries
  19. Ligand-based Pharmacophore Design
  20. Ligand-based pharmacophore modeling, including automatic classification of chemical features, feature weights and generation of exclusion volume spheres
  21. Automated training set selection by pharmacophore-based cluster analysis

Quantity: Unlimited seats

Period of Performance: 9/26/2024-9/25/2025

CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION

The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted. Specifically, Inte:ligand Softwareentwicklungs- und Consulting GmbH is the only vendor in the marketplace that can provide the products required by NCATS.

The intended source is:

Inte:ligand Softwareentwicklungs- und Consulting GmbH

Clemens-Maria Hofbauer-G. 6

2344 Maria Enzersdorf 1070 Wien/Vienna, Austria

CLOSING STATEMENT

THIS SYNOPSIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. However, interested parties may identify their interest to receive a Request for Quotation (RFQ) and capability to respond to this notice.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Unique Entity Identifier (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

All responses must be received by the closing date and time of this announcement and must reference the solicitation number, 75N95024Q00416. Responses must be submitted electronically to Maggie Brant, Contract Specialist, at maggie.brant@nih.gov.  U.S. Mail and fax responses will not be accepted.

Similar open opportunities

Opportunity Agency Set-aside Responses due
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
ASIT. TO 1 year software support from ArgonSoft (Notice of Intent to sole source) Bethesda, Maryland 20814, United States · NAICS 513210 NIH Clinical Center No set-aside
Notice of Intent to Sole Source – Boston Scientific Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Hidex 600SLe Liquid Scintillation Counter United States · NAICS 334516 National Institute on Drug Abuse No set-aside
Access to Web of Science, EndNote and Incites Bethesda, Maryland 20892, United States · NAICS 519290 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity